The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Molecular classification of sunitinib response in metastatic renal cell carcinoma (mRCC) patients by gene expression profiling.
V. J. Thodima
No relevant relationships to disclose
A. M. Molina
Research Funding - Novartis
X. Jia
No relevant relationships to disclose
J. Zhang
No relevant relationships to disclose
M. E. Georges
No relevant relationships to disclose
S. Patil
No relevant relationships to disclose
V. E. Reuter
No relevant relationships to disclose
R. J. Motzer
Research Funding - Pfizer
R. S. Chaganti
No relevant relationships to disclose